The INNs and outs of antibody nonproprietary names
MAbs. January 2016, 8 (1): 1-9
Temporal- and embryonic lineage-dependent regulation of human vascular SMC development by Notch3
Stem Cells Dev.. December 2014
Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from ligand binding domain
Scientific Reports. August 2017
Development of a ‘mouse and human cross-reactive’ affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy
Protein Eng. Des. Sel.. March 2014. 27:179
Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cells
Methods. September 2012, 58 (1): 69-78
Quantitative Visualization of DNA G-quadruplex Structures in Human Cells
Nature Chemistry. January 2013
Targeting the sheddase activity of ADAM17 by an anti-ADAM17 antibody D1(A12) inhibits head and neck squamous cell carcinoma cell proliferation and motility via blockage of bradykinin induced HERs tran
Int J Biol Sci. Jun. June 2014, 10 (7): 702-14
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?
BMJ Journals. December 2018, 78 (2)
A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.
Nat Med. 2017 Sep;23(9):1086-1094
A new anti-mesothelin antibody targets selectively the membrane-associated form.
MAbs. 2017 Apr;9(3):567-577